LORRIE KNAPP: Open Payments
NPI 1316198609 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,274 in 74 payments from 18 companies in 2025. Trend: 2023 $827 · 2024 $727 · 2025 $2,274
Food & beverage: $2,274
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $476 |
| ABBVIE INC. | 17 | $315 |
| Amgen Inc. | 11 | $204 |
| AstraZeneca Pharmaceuticals LP | 4 | $201 |
| Neurocrine BioSciences, Inc. | 1 | $140 |
| Phathom Pharmaceuticals, Inc. | 3 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $132 |
| Edwards Lifesciences Corporation | 1 | $123 |
| PFIZER INC. | 2 | $121 |
| Insulet Corporation | 1 | $114 |
Products named: Ozempic, Wegovy, VRAYLAR, INGREZZA, VOQUEZNA, CAPLYTA, EVENITY, QULIPTA.
Industry payments across FL — which companies pay providers there.
